Previous research has suggested that the use of ecstasy is primarily a white phenomenon. To date, however, these studies have all been conducted at single points in time. No research has examined the temporal relationship between race and the use of ecstasy. In the current study, data collected from 10,088 high school seniors surveyed through the Monitoring the Future (MTF) study between 1996 and 1999 are analyzed. Chi-square statistics are used to explore the temporal relationship between race and the use of ecstasy during this time frame. Statistically significant relationships between race and ecstasy use are discerned. Policy implications are assessed in light of the findings.
Get full access to this article
View all access options for this article.
References
1.
BeckJ. and RosenbaumM., In Pursuit of Ecstasy, State University of New York Press, New York, 1995.
2.
SeymourR. B., MDMA, Haight-Asbury Publications, San Francisco, California, 1986.
3.
ShulginA., History of MDMA, in Ecstasy: The Clinical, Pharmacological and Neurotoxic Effects of the Drug MDMA, PeroutkaS. J. (ed.), Kluwer Academic Publishers, Norwell, Massachusetts, pp. 1–20, 1990.
4.
GreerG. R. and TolbertR., A Method of Conducting Therapeutic Sessions with MDMA, Journal of Psychoactive Drugs, 30: 4, pp. 371–379, 1998.
5.
GreerG. R. and TolbertR., The Therapeutic Use of MDMA, in Ecstasy: The Clinical, Pharmacological and Neurotoxic Effects of the Drug MDMA, PeroutkaS. J. (ed.), Kluwer Academic Publishers, Norwell, Massachusetts, pp. 21–35, 1990.
6.
GrinspoonL. and BakalarJ. B., Can Drugs be Used to Enhance the Psychotherapeutic Process?American Journal of Psychotherapy, 40: 3, pp. 393–403, 1986.
7.
PeroutkaS. J., Incidence of Recreational Use of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) on an Undergraduate Campus, New England Journal of Medicine, 317: 24, pp. 1542–1543, 1987.
8.
ShulginA. and NicholsD., Characterization of Three New Psychotomimetics, in The Psychopharmacology of Hallucinogens, StillmanR. J. and WilletteR. E. (eds.), Pergamon Press, New York, 1978.
9.
RandolphW. F., International Drug Scheduling: Convention on Psychotropic Substances, Stimulant and/or Hallucinogenic Drugs, Federal Register, 49: 140, pp. 29273–29274, 1984.
10.
MullenF. M., Schedules of Controlled Substances: Proposed Placement of 3,4-Methylenedioxymethamphetamine into Schedule I, Federal Register, 49: 146, pp. 30210–30211, 1984.
11.
RicaurteG. A.BryanG.StraussL.SeidenL., and SchusterC., Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals, Science, 229, pp. 986–988, 1985.
12.
HolstenD. W. and SchieserD. W., Controls Over the Manufacture of MDMA, Journal of Psychoactive Drugs, 18: 4, pp. 371–372, 1986.
13.
LawnJ. C., Schedules of Controlled Substances: Temporary Placement of 3,4-Methylenedioxymethamphetamine (MDMA) into Schedule 1, Federal Register, 50: 105, pp. 23118–23120, 1985.
14.
GrinspoonL., Written Testimony Submitted on Behalf of Dr. Grinspoon and Greer, Professors Bakalar and Roberts, Drug Enforcement Administration Law Hearings, Docket No. 84-48, U.S. Department of Justice, Washington, D.C., 1985.
15.
LawnJ. C., Schedules of Controlled Substances: Scheduling of 3,4-Methylenedioxymethamphetamine (MDMA) into Schedule 1 of the Controlled Substances Act, Federal Register, 51: 198, pp. 36552–36560, 1988.
16.
McCannU. D.RidenourA.ShamanY., and RicaurteG. A., Serotonin Neurotoxicity after 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): A Controlled Study, Neuropsychopharmacology, 10: 2, pp. 129–138, 1994.
17.
RicaurteG. A.McCannU. D.SzaboZ., and ScheffelU., Toxicodynamics and Long-Term Toxicity of the Recreational Drug, 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”), Toxicology Letters, 112–113, pp. 143–146, 2000.
18.
AmeyC. H. and AlbrechtS. L., Race and Ethnic Differences in Adolescent Drug Use: The Impact of Family Structure and the Quantity and Quality of Parental Interaction, Journal of Drug Issues, 28: 2, pp. 283–299, 1998.
19.
ChilcoatH. D. and SchutzC. G., Racial/Ethnic and Age Differences in Crack Use within Neighborhoods, Addictions Research, 3: 2, pp. 103–111, 1995.
20.
HoffmanJ. H.WelterJ. W., and BarnesG. M., Co-Occurrence of Alcohol and Cigarette Use among Adolescents, Addictive Behaviors, 26, pp. 63–78, 2001.
21.
KandelD. B.SingleE., and KesslerR., The Epidemiology of Drug Use among New York State High School Students: Distribution, Trends, and Changes in Rates of Use, American Journal of Public Health, 66, pp. 43–53, 1976.
22.
OettingE. R.DeffenbacherJ. L.TaylorM. J.LutherN.BeauvaisF., and EdwardsR. W., Methamphetamine Use by High School Seniors: Recent Trends, Gender and Ethnicity Differences, and Use of Other Drugs, Journal of Child and Adolescent Substance Abuse, 10: 1, pp. 33–51, 2000.
23.
WallaceJ. M. and BachmanJ. G., Explaining Racial/Ethnic Differences in Adolescent Drug Use: The Impact of Background and Lifestyle, Social Problems, 38: 3, pp. 333–357, 1991.
24.
WarheitG. J. and VegaW. A., A Comparative Analysis of Cigarette, Alcohol and Illicit Drug Use among an Ethnically Diverse Sample of Hispanic, African-American, and Non-Hispanic White Adolescents, Journal of Drug Issues, 26: 4, pp. 901–922, 1996.
25.
YacoubianG., Correlates of Ecstasy Use among 10th Graders Surveyed through Monitoring the Future, Journal of Psychoactive Drugs, in press.
26.
YacoubianG.ArriaA.FostE., and WishE. D., Estimating the Prevalence of Ecstasy Use among Juvenile Offenders, Journal of Psychoactive Drugs, in press.
27.
ArriaA.YacoubianG.FostE., and WishE. D., Ecstasy Use among Club Rave Attendees, Archives of Pediatrics and Adolescent Medicine, 156, pp. 295–296.
28.
YacoubianG., Assessing ADAM's Domain: Past, Present, and Future, Contemporary Drug Problems, 27, pp. 121–135, 2000.
29.
Substance Abuse and Mental Health Services Administration, Summary of Findings from the 1999 National House Household Survey on Drug Abuse, U.S. Department of Health and Human Services, Rockville, Maryland, 2000.
30.
Substance Abuse and Mental Health Services Administration, Mid-Year 2000 Preliminary Emergency Department Data from the Drug Abuse Warning Network, U.S. Department of Health and Human Services, Rockville, Maryland, 2001.
31.
Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network Annual Medical Examiners Data 1999, U.S. Department of Health and Human Services, Rockville, Maryland, 2000.
32.
JohnstonL. D.O'MalleyP. M., and BachmanJ. G., National Survey Results on Drug Use from the Monitoring the Future Study, 1975–2000 (Volume I), U.S. Department of Health and Human Services, Rockville, Maryland, 2001.
33.
National Institute of Justice, 1999 Arrestee Drug Abuse Monitoring (ADAM), Annual Report, U.S. Department of Justice, Washington, D.C., 2000.
34.
ChaikenM. R., The Rise of Crack and Ice: Experiences in Three Locales, National Institute of Justice, Washington, D.C., 1993.
35.
GolubA. L.HakeemF., and JohnsonB. D., Monitoring the Decline in the Crack Epidemic with Data from the Drug Use Forecasting Program, National Institute of Justice, Washington, D.C., 1996.
36.
HaynerG. N. and McKinneyH. E., MDMA: The Dark Side of Ecstasy, Journal of Psychoactive Drugs, 18, pp. 341–347, 1986.
37.
PeroutkaS. J.NewmanH., and HarrisH., Subjective Effects of 3,4-Methylenedioxymethamphetamine in Recreational Users, Neuropsychopharmacology, 1, pp. 273–277, 1988.
38.
BollaK. I.McCannU. D., and RicaurteG. A., Memory Impairment in Abstinent MDMA (“Ecstasy”) Users, Neurology, 51, pp. 1532–1537, 1999.
39.
MorganM. J., Ecstasy (MDMA): A Review of Its Possible Persistent Psychological Effects, Psychopharmacology, 152: 3, pp. 230–248, 2000.
40.
ParrottA. C.SiskE., and TurnerJ. J. D., Psychobiological Problems in Heavy “Ecstasy” (MDMA) Polydrug Users, Drug and Alcohol Dependence, 60, pp. 105–110, 2000.
41.
SolowijN.HallW., and LeeN., Recreational MDMA Use in Sydney: A Profile of ‘Ecstasy’ Users and Their Experiences with the Drug, British Journal of Addictions, 87, pp. 1161–1172, 1992.
42.
HenryJ. A., Ecstasy and Serotonin Depletion, Lancet, 347, p. 833, 1996.
43.
HenryJ. A., Ecstasy and the Dance of Death, British Medical Journal, 305, pp. 5–6, 1992.
44.
KarchS., Ecstasy in Glasgow, Forensic Drug Abuse Advisor, 7: 3, p. 19, 1995.
45.
KarchS., “Ecstasy”: The Dance of Death, Forensic Drug Abuse Advisor, 4: 7, pp. 49–50, 1992.
46.
HenryJ. A.JeffreysK. J., and DawlingS., Toxicity and Deaths from 3,4-Methylenedioxymethamphetamine (“Ecstasy”), Lancet, 340, pp. 284–287, 1992.
